drugset / Trial / NCT00646711

Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

NCT00646711

Phase 2 Completed 16 enrolled Abbott
Non-randomizedCrossoverOpen-labelTreatment

Summary

To assess the tolerability of switching from Depakote Sprinkle Capsules or Depakote tablets to Depakote ER tablets in the pediatric population.

Timeline

Start
2003-02
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule